{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T17:30:40Z","timestamp":1781544640482,"version":"3.54.5"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007113","name":"Sexual Medicine Society of North America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007113","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007113","name":"Sexual Medicine Society of North America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007113","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsm.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Postorgasmic illness syndrome (POIS) is a rare syndrome of unknown etiology where patients experience distressing physical and psychological after ejaculatory sequelae.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To better characterize the epidemiology, symptomatology, disease course, and treatment of POIS, with specific interest placed on examining relationships between disease presentation and measures of disease burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A 30-item questionnaire was distributed to an online community of patients with POIS from June 2019 to January 2020. We assessed diagnostic criteria and clusters of symptomatology described in prior studies. Outcome measures include self-reported measures of symptom severity, disease burden, and behavioral changes. Statistical correlations were assessed with Pearson's chi-squared (\u03c72) and ordinal regression analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes<\/jats:title>\n                    <jats:p>The main outcome measures of this study are self-reported measures of symptom severity, disease burden, and behavioral changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The sample consisted of 302 men (mean age: 32.6\u00a0\u00b1\u00a011.4\u00a0years, mean age of onset: 19.1\u00a0\u00b1\u00a07.8\u00a0years) with 89% satisfying \u22653 diagnostic criteria. Common symptoms were difficulty concentrating (254, 84%), extreme fatigue (250, 83%), irritability (225, 74%), and muscle weakness (212, 70%). Common symptom clusters were general (219, 72%), muscle (137, 45%), and head (93, 31%). Common behavioral modifications were avoiding masturbation (215, 71%), schedule changes (213, 71%), and abstinence (186, 62%). Head and throat symptom clusters demonstrated worse disease burden outcomes. Professional medical advice was sought by 51% of participants. Attempted treatments included pharmacotherapy, vitamins, supplements, and herbs with variable efficacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Implications<\/jats:title>\n                    <jats:p>This study further characterizes POIS, including how patients respond to the condition, how it is treated in the community, and presentations that may be associated with more severe disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Strengths &amp; Limitations<\/jats:title>\n                    <jats:p>This is the largest study to date that concerns patients suffering from POIS and includes a diverse, global population. Limitations include that the survey was only administered in English and within 1 online community, that results were self-reported, and that the response rate was low (32%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Characterizing symptom cluster, but not number of diagnostic criteria, may offer prognostic value, and investigation to elucidate pathophysiology and potential treatments for POIS is necessary.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.jsxm.2020.08.020","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T05:40:57Z","timestamp":1601444457000},"page":"2229-2235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Analysis of the Symptomatology, Disease Course, and Treatment of Postorgasmic Illness Syndrome in a Large Sample"],"prefix":"10.1093","volume":"17","author":[{"given":"Caleb","family":"Natale","sequence":"first","affiliation":[{"name":"Department of Urology , New Orleans, LA , USA"},{"name":"Tulane University School of Medicine , New Orleans, LA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gabrielson","sequence":"additional","affiliation":[{"name":"Johns Hopkins School of Medicine , Baltimore, MD , USA"},{"name":"James Buchanan Brady Urological Institute , Baltimore, MD , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoang Minh","family":"Tue Nguyen","sequence":"additional","affiliation":[{"name":"Department of Urology , New Orleans, LA , USA"},{"name":"Tulane University School of Medicine , New Orleans, LA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Dick","sequence":"additional","affiliation":[{"name":"Department of Urology , New Orleans, LA , USA"},{"name":"Tulane University School of Medicine , New Orleans, LA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne J.G.","family":"Hellstrom","sequence":"additional","affiliation":[{"name":"Department of Urology , New Orleans, LA , USA"},{"name":"Tulane University School of Medicine , New Orleans, LA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,30]]},"reference":[{"key":"2023011111111314500_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.sxmr.2017.08.006","article-title":"Post-Orgasmic Illness syndrome: a review","volume":"6","author":"Nguyen","year":"2018","journal-title":"Sex Med Rev"},{"key":"2023011111111314500_bib2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/009262302760328280","article-title":"Postorgasmic Illness syndrome: two cases","volume":"28","author":"Waldinger","year":"2002","journal-title":"J\u00a0Sex Marital Ther"},{"key":"2023011111111314500_bib3","first-page":"840","article-title":"Postorgasmic Illness syndrome (POIS) in a Chinese man: no proof for IgE-mediated allergy to semen","volume":"12","author":"Jiang","year":"2015","journal-title":"J\u00a0Sex Med"},{"key":"2023011111111314500_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12610-019-0093-7","article-title":"Post Orgasmic Illness syndrome: what do we know till now?","volume":"29","author":"Abdessater","year":"2019","journal-title":"Basic Clin Androl"},{"key":"2023011111111314500_bib5","doi-asserted-by":"crossref","first-page":"101078","DOI":"10.1016\/j.eucr.2019.101078","article-title":"Successful treatment of Post-Orgasmic Illness syndrome with human chorionic gonadotropin","volume":"29","author":"Bolanos","year":"2019","journal-title":"Urol Case Rep"},{"key":"2023011111111314500_bib6","doi-asserted-by":"publisher","DOI":"10.1038\/s41443-020-0314-9","article-title":"Clinical experience with Post-Orgasmic Illness syndrome (POIS) patients-characteristics and possible treatment modality","author":"Reisman","year":"2020","journal-title":"Int J Impot Res"},{"key":"2023011111111314500_bib7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41443-019-0154-7","article-title":"First assessment of the validity of the only diagnostic criteria for Postorgasmic Illness syndrome (POIS)","volume":"31","author":"Strashny","year":"2019","journal-title":"Int J Impot Res"},{"key":"2023011111111314500_bib8","article-title":"Post Orgasmic Illness syndrome (P.O.I.S.) \u2013 statistics center","author":"POIS Center.com","year":"2019"},{"key":"2023011111111314500_bib9","article-title":"Post Orgasmic Illness syndrome (POIS)","author":"The Naked Scientists.com"},{"key":"2023011111111314500_bib10","article-title":"Post Orgasmic Illness syndrome (POIS)","author":"Facebook.com"},{"key":"2023011111111314500_bib11","first-page":"1171","article-title":"Hyposensitization therapy with autologous semen in two Dutch caucasian males: beneficial effects in Postorgasmic Illness syndrome (POIS; Part 2)","volume":"8","author":"Waldinger","year":"2011","journal-title":"J\u00a0Sex Med"},{"key":"2023011111111314500_bib12","first-page":"1164","article-title":"Postorgasmic Illness syndrome (POIS) in 45 Dutch caucasian males: clinical characteristics and evidence for an immunogenic pathogenesis (part 1)","volume":"8","author":"Waldinger","year":"2011","journal-title":"J\u00a0Sex Med"},{"key":"2023011111111314500_bib13","doi-asserted-by":"crossref","first-page":"602","DOI":"10.21037\/tau.2016.07.01","article-title":"Post Orgasmic Illness syndrome (POIS)","volume":"5","author":"Waldinger","year":"2016","journal-title":"Transl Androl Urol"},{"key":"2023011111111314500_bib14","first-page":"1976","article-title":"Postorgasm Illness syndrome--a spectrum of illnesses","volume":"7","author":"Ashby","year":"2010","journal-title":"J\u00a0Sex Med"},{"key":"2023011111111314500_bib15","article-title":"Post Orgasmic Illness Syndrome (P.O.I.S.)"},{"key":"2023011111111314500_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.21037\/tau.2016.05.11","article-title":"The epidemiology of premature ejaculation","volume":"5","author":"Saitz","year":"2016","journal-title":"Transl Androl Urol"},{"key":"2023011111111314500_bib17","doi-asserted-by":"crossref","first-page":"e017173","DOI":"10.1136\/bmjopen-2017-017173","article-title":"Prevalence of depression and depressive symptoms among outpatients: a systematic review and meta-analysis","volume":"7","author":"Wang","year":"2017","journal-title":"BMJ Open"},{"key":"2023011111111314500_bib18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jamapsychiatry.2017.0056","article-title":"Cross-sectional comparison of the epidemiology of DSM-5 generalized anxiety disorder across the globe","volume":"74","author":"Ruscio","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"2023011111111314500_bib19","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.esxm.2017.12.004","article-title":"Intralymphatic immunotherapy with autologous semen in a Korean man with Post-Orgasmic Illness syndrome","volume":"6","author":"Kim","year":"2018","journal-title":"Sex Med"},{"key":"2023011111111314500_bib20","first-page":"S41","article-title":"Post-Orgasmic Illness syndrome: a case report and literature review with contemporary treatment considerations","volume":"17 Suppl 1","author":"Fainberg","year":"2020","journal-title":"J\u00a0Sex Med"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609520308912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609520308912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/17\/11\/2229\/48526832\/jsm_17_11_2229.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/17\/11\/2229\/48526832\/jsm_17_11_2229.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T09:47:58Z","timestamp":1675936078000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/17\/11\/2229\/6973735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,30]]},"references-count":20,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,9,30]]},"published-print":{"date-parts":[[2020,11,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jsxm.2020.08.020","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738784244.793580628","asserted-by":"object"}]},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2020,11]]},"published":{"date-parts":[[2020,9,30]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of the Symptomatology, Disease Course, and Treatment of Postorgasmic Illness Syndrome in a Large Sample","name":"articletitle","label":"Article Title"},{"value":"The Journal of Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsxm.2020.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}